Occult hepatits B virus infection and cryptogenic chronic hepatits in an area with intermediate prevalence of HBV infection

World Journal of Gastroenterology

Volumn 12, Issue 31, 2006, Pages 5048-5050

  Kaviani, Mohammad Javad ^a   Behbahani, Behzad ^a   Mosallaii, Mohammad Jafar ^b   Sari Aslani, Fatemeh ^b   Taghavi, Seyed Alireza ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; VIRUS DNA; PRIMER DNA;

ADULT; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; FEMALE; HEPATITIS B; HUMAN; IRAN; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PREVALENCE; QUALITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; AUTOIMMUNE DISEASE; CHEMISTRY; GENETICS; HEPATITIS B VIRUS; METABOLISM; MIDDLE AGED; VIROLOGY;

ADULT; AUTOIMMUNE DISEASES; DNA PRIMERS; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; IRAN; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREVALENCE;

EID: 33748316801     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i31.5048     Document Type: Article

References (17)

1. Chazouilleres O, Mamish D, Kim M, Carey K, Ferrell L, Roberts JP, Ascher NL, Wright TL. "Occult" hepatitis B virus as source of infection in liver transplant recipients. Lancet 1994; 343:142-146
2. Tai DI, Chung ZJ, Chen CL, Eng HL. Reappearance of HBsAg with compartmentalized different HBV strains in allograft versus PBMC of the recipient. J Gastroenterol 2001; 36: 200-205
3. Ghany MG, Ayola B, Villamil FG, Gish RG, Rojter S, Vierling JM, Lok AS. Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis. Hepatology 1998; 27: 213-222
4. Iannitto E, Minardi V, Calvaruso G, Mule A, Ammatuna E, Di Trapani R, Ferraro D, Abbadessa V, Craxi A, Di Stefano R. Hepatitis B virus reactivation and alemtuzumab therapy. Eur J Haematol 2005; 74: 254-258
5. Davis CL, Gretch DR, Carithers RL Jr. Hepatitis B and transplantation. Infect Dis Clin North Am 1995; 9: 925-941
6. Huo TI, Wu JC, Lee PC, Chau GY, Lui WY, Tsay SH, Ting LT, Chang FY, Lee SD. Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis. Hepatology 1998; 28: 231-236
7. Zhang YY, Nordenfelt E, Hansson BG. Increasing heterogeneity of the 'a' determinant of HBsAg found in the presumed late phase of chronic hepatitis B virus infection. Scand J Infect Dis 1996; 28: 9-15
8. Liang TJ, Baruch Y, Ben-Porath E, Enat R, Bassan L, Brown NV, Rimon N, Blum HE, Wands JR. Hepatitis B virus infection in patients with idiopathic liver disease. Hepatology 1991; 13: 1044-1051
9. Chung HT, Lai CL, Lok AS. Pathogenic role of hepatitis B virus in hepatitis B surface antigen-negative decompensated cirrhosis. Hepatology 1995; 22:25-29
10. Paterlini P, Gerken G, Nakajima E, Terre S, D'Errico A, Grigioni W, Nalpas B, Franco D, Wands J, Kew M. Polymerase chain reaction to detect hepatitis-B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen. N Engl J Med 1990; 323: 80-85
11. Seddigh-Tonekaboni S, Waters JA, Jeffers S, Gehrke R, Ofenloch B, Horsch A, Hess G, Thomas FIC, Karayiannis P. Effect of variation in the common "a" determinant on the antigenicity of hepatitis B surface antigen. J Med Virol 2000; 60: 113-121
12. Weinberger KM, Bauer T, Bohm S, Jilg W. High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum. J Gen Virol 2000; 81: 1165-1174
13. Chung HT, Lee JS, Lok AS. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg. Hepatology 1993; 18: 1045-1049
14. Kato J, Hasegawa K, Torii N, Yamauchi K, Hayashi N. A molecular analysis of viral persistence in surface antigen-negative chronic hepatitis B. Hepatology 1996; 23: 389-395
15. Chan HL, Tsang SW, Leung NW, Tse CH, Hui Y, Tam JS, Chan FK, Sung JJ. Occult HBV infection in cryptogenic liver cirrhosis in an area with high prevalence of HBV infection. Am J Gastroenterol 2002; 97: 1211-1215
16. Merat S, Malekzadeh R, Rezvan H, Khatibian M. Hepatitis B in Iran. Archives of Iranian Medicine 2000; 4 (http://www.ams.ac.ir/AIM/0034/ merat0034.html)
17. Gish RG, Lau JY, Brooks L, Fang JW, Steady SL, Imperial JC, Garcia-Kennedy R, Esquivel CO, Keeffe EB. Ganciclovir treatment of hepatitis B virus infection in liver transplant recipients. Hepatology 1996; 23: 1-7